Pulmonary hypertension, endothelial dysfunction, and their correction with lisinopril in patients with heart failure in combination of ischemic heart disease and chronic obstructive pulmonary disease
Pribylov, S.A.
Kardiologiia 46(9): 36-40
2006
ISSN/ISBN: 0022-9040 PMID: 17047621 Document Number: 602667
The paper contains review of the role of endothelial dysfunction in heart failure in patients with combination of ischemic heart disease and chronic obstructive pulmonary disease and discussion of results of a study in which it was established that lisinopril (10 mg/day) caused attenuation of pulmonary hypertension, improvement of right ventricular systolic function and diastolic ventricular filling at the background of correction of vascular tone.
Document emailed within 1 workday
Related Documents
Akhmineeva, A.K. 2014: Biochemical markers of endothelial dysfunction in chronic obstructive pulmonary disease concurrent with hypertensive disease or coronary heart disease Terapevticheskii Arkhiv 86(3): 20-23Grigor'eva, N.I.; Sharabrin, E.G.; Kuznetsov, A.N.; Mazalov, K.V.; Kontorshchikova, K.N.; Koroleva, E.F. 2009: Effects of beta 1-adrenoblocker bisoprolol on endothelial dysfunction in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease Terapevticheskii Arkhiv 81(3): 28-31
Volchkova, E.A.; Zateĭshchikova, A.A.; Shavrin, I.V.; Kiselev, D.G.; Brazhnik, V.A.; Privalov, D.V.; Doshchitsin, V.L.; Zateĭshchikov, D.A. 2012: Association of parameters of heart rate variability with severity of bronchial obstruction and presence of pulmonary hypertension in patients with chronic obstructive pulmonary disease Kardiologiia 52(7): 42-49
Shoĭkhet, I.N.; Klester, E.B.; Golovin, V.A. 2008: Heart rhythm disturbances in patients with chronic obstructive pulmonary disease in aggregate with coronary heart disease Klinicheskaia Meditsina 86(3): 21-26
Provotorov, V.M.; Budnevskiĭ, A.V.; Semenkova, G.G.; Shishkina, E.S. 2015: Proinflammatory Cytokines in Combination of Coronary Heart Disease and Chronic Obstructive Pulmonary Disease Klinicheskaia Meditsina 93(2): 5-9
Borovkov, N.N.; Grigor'eva, N.I. 2006: Clinicofunctional characteristics of the heart in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease Terapevticheskii Arkhiv 78(12): 24-27
Damarla, M.; Celli, B.R.; Mullerova, H.X.; Pinto-Plata, V.M. 2006: Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure Respiratory Care 51(10): 1120-1124
Bu, X.; Wang, C.; Pang, B. 2003: Effects of leukotriene receptor antagonist on chronic obstructive [correction of obstractive] pulmonary disease induced pulmonary hypertension Chinese Medical Journal 116(3): 459-461
Mangelsdorff, G.; Borzone, G.; Leiva, A.; Martínez, A.; Lisboa, C. 2001: Strength of inspiratory muscles in chronic heart failure and chronic pulmonary obstructive disease Revista Medica de Chile 129(1): 51-59
Shoĭkhet, I.N.; Klester, E.B. 2010: Digestive system pathology in patients with chronic obstructive pulmonary disease concurrent with coronary heart disease Terapevticheskii Arkhiv 82(2): 25-28
Ol'binskaia, L.I.; Sizova, Z.M.; Kolbaia, N.G. 2007: Endothelial dysfunction in patients with chronic heart failure, and possibilities of its correction with isosorbide-5-mononitrates Klinicheskaia Meditsina 85(1): 27-31
Sazhina, E.I.; Kozlova, I.V.; Rebrov, A.P.; Al'tshuler, M.I. 2006: The degree of inflammation and endothelial dysfunction in treatment of chronic heart failure in patients with coronary artery disease Klinicheskaia Meditsina 84(12): 20-24
Zhdan, V.; Khaymenova, G.; Shilkina, L.; Martynyuk, D.; Babanina, M.; Mamontova, T. 2017: Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease Wiadomosci Lekarskie 70(2 Part 2): 303-305
Lewczuk, J.; Piszko, P.; Jagas, J.; Wrabec, K. 2005: Impact of 30 day therapy with doxazosin--alpha1 adrenergic blocker on pulmonary hemodynamics in patients with secondary pulmonary hypertension due to chronic obstructive pulmonary disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(105): 279-281
Zunnunov, Z.R. 2010: The clinical efficiency and safety of iodide-bromine balneotherapy in patients with coronary heart disease concurrent with chronic obstructive pulmonary disease Terapevticheskii Arkhiv 82(1): 24-27
Alexandrova, A.A.; Kolos, I.P.; Dupik, N.V.; Lazebnik, L.B. 2015: Unmodified Diameter V. Porta. in 79-Year-Old Patient with Congestive Heart Failure and Severe Pulmonary Hypertension in the Setting of Complex Congenital Heart Disease--Patent Foramen Ovale at the Confluence of the left Pulmonary Veins into the V. Cava Superior and Mixed (Hcv) Liver Cirrhosis Eksperimental'naia i Klinicheskaia Gastroenterologiia 6: 99-102
Titova, O.N.; Ignat'ev, V.A.; Didur, M.D.; Kameneva, M.Iu.; Sukhovskaia, O.A. 2008: Combination of thiotropium bromide with almitrine and pulmonary rehabilitation in the treatment of patients with chronic obstructive pulmonary disease Terapevticheskii Arkhiv 80(3): 28-33
Rahimi-Rad, M.Hossein.; Rahimi, P.; Rahimi, B.; Gholamnaghad, M. 2014: Serum CA-125 level in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension Pneumologia 63(3): 164-166
Rahimi-Rad, M.H.; Rahimi, P.; Rahimi, B.; Gholamnaghad, M. 2014: Serum CA-125 level in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension Pneumologia 63(3): 164-166
Marchman, H.B.; Skolnick, J.L. 1992: Blood pressure changes in patients with chronic obstructive pulmonary disease and hypertension completing phase II pulmonary rehabilitation Journal of the Kentucky Medical Association 90(10): 503-505